These studies indicate that persistent rab5 overactivation through βCTF–APPL1 interactions constitutes a novel βCTF-dependent and Aβ-independent, pathogenic pathway contributing to the development of AD and DS. This evidence concerns the gene RAB5A and Dravet syndrome.